Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter are often left out.
FDA begins comprehensive safety assessment of widely used preservative BHA, signalling tougher scrutiny of legacy food additives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results